SCHEMBL6157451

SCHEMBL6157451

CN(NC=O)C(=N)CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10383795 0.70
Hydrochloric Acid SCHEMBL9794681 0.68
SCHEMBL27576692 0.64
SCHEMBL24369884 0.62
SCHEMBL6153763 0.61
SCHEMBL16154045 0.61
SCHEMBL11336483 0.59
SCHEMBL30827479 0.59
SCHEMBL55417 0.58
SCHEMBL5591327 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1551832-A1 8-AZABICYCLO[3.2.1]OCTANE ETHER DERIVATIVES AND THEIR USE AS NEUROKININ RECEPTOR ANTAGONISTS MERCK SHARP &amp; DOHME LTD. (GB) 2005-07-13 EP disclosed
US-6727249-B2 FOR THERAPY AND PROPHYLAXIS OF PAIN OR INFLAMMATION, MIGRAINE, EMESIS, POSTHERPETIC NEURALGIA, DEPRESSION OR ANXIETY MERCK SHARP & DOHME LTD. (GB) 2004-04-27 US disclosed
WO-2004031185-A1 8-AZABICYCLO[3.2.1]OCTANE ETHER DERIVATIVES AND THEIR USE AS NEUROKININ RECEPTOR ANTAGONISTS MERCK SHARP & DOHME LIMITED (GB) 2004-04-15 WO disclosed
US-20020193402-A1 Azabicyclic ether derivatives and their use as therapeutic agents MERCK SHARP & DOHME LTD. (GB) 2002-12-19 US disclosed